Lokken Investment Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$483K Sell
18,969
-110
-0.6% -$2.71K 0.17% 92
2025
Q2
$462K Sell
19,079
-327
-2% -$7.63K 0.18% 85
2025
Q1
$492K Sell
19,406
-371
-2% -$9.71K 0.21% 82
2024
Q4
$525K Sell
19,777
-1,740
-8% -$47.2K 0.23% 80
2024
Q3
$623K Sell
21,517
-321
-1% -$9.36K 0.26% 79
2024
Q2
$611K Sell
21,838
-227
-1% -$6.25K 0.29% 77
2024
Q1
$612K Sell
22,065
-131
-0.6% -$3.63K 0.31% 77
2023
Q4
$639K Sell
22,196
-11,565
-34% -$350K 0.36% 67
2023
Q3
$1.12M Sell
33,761
-474
-1% -$16.8K 0.73% 32
2023
Q2
$1.26M Buy
34,235
+2,898
+9% +$113K 0.82% 30
2023
Q1
$1.28M Buy
31,337
+1,142
+4% +$49.3K 0.97% 26
2022
Q4
$1.55M Buy
30,195
+889
+3% +$42.6K 1.22% 22
2022
Q3
$1.28M Buy
29,306
+203
+0.7% +$9.86K 1.11% 25
2022
Q2
$1.53M Buy
29,103
+466
+2% +$23.7K 1.24% 22
2022
Q1
$1.41M Buy
28,637
+244
+0.9% +$12.7K 1.11% 23
2021
Q4
$1.68M Buy
28,393
+899
+3% +$44.5K 1.2% 22
2021
Q3
$1.18M Sell
27,494
-414
-1% -$18.3K 0.94% 25
2021
Q2
$1.09M Buy
27,908
+533
+2% +$20.7K 0.89% 26
2021
Q1
$992K Buy
27,375
+1,216
+5% +$43.2K 0.88% 28
2020
Q4
$963K Buy
+26,159
New +$960K 0.88% 26

Other funds holding PFE

Lokken Investment Group's PFE Position: Q3 2025 in Review

Lokken Investment Group reduced its Pfizer (PFE) stake by 0.58% in Q3 2025, selling an estimated $2.71K and leaving 18,969 shares worth $483K. The position accounts for 0.17% of the portfolio, ranked #92.

Lokken Investment Group first reported a position in PFE in Q4 2020 and has held it in 20 quarters since. The position peaked at $1.68M in Q4 2021. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Lokken Investment Group held 18,969 shares of Pfizer worth $483K as of Q3 2025.
  • Lokken Investment Group sold 110 Pfizer shares in Q3 2025, an estimated $2.71K.
  • Pfizer made up 0.17% of Lokken Investment Group's portfolio in Q3 2025, its #92 holding.
  • Lokken Investment Group first reported a position in Pfizer in Q4 2020 and has held it in 20 quarters since.
  • Lokken Investment Group's Pfizer position peaked at $1.68M in Q4 2021.
  • 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Lokken Investment Group's 13F filing for Q3 2025, filed 5 Nov 2025.